163 related articles for article (PubMed ID: 7734108)
21. Dopamine uptake by mouse neuroblastoma N1E-115 cells stably expressing human dopamine transporter is differentially inhibited by anti-idiotypic ab2beta antibodies mimicking the configuration of cocaine.
Ho M; Segre M
Brain Res; 2000 Jul; 872(1-2):231-5. PubMed ID: 10924700
[TBL] [Abstract][Full Text] [Related]
22. A novel mechanism of dopamine neurotoxicity involving the peripheral extracellular and the plasma membrane dopamine transporter.
Liu Z; Zhang J; Fei J; Guo L
Neuroreport; 2001 Oct; 12(15):3293-7. PubMed ID: 11711873
[TBL] [Abstract][Full Text] [Related]
23. Protein kinase-mediated bidirectional trafficking and functional regulation of the human dopamine transporter.
Pristupa ZB; McConkey F; Liu F; Man HY; Lee FJ; Wang YT; Niznik HB
Synapse; 1998 Sep; 30(1):79-87. PubMed ID: 9704884
[TBL] [Abstract][Full Text] [Related]
24. Striatal transporter for dopamine: catechol structure-activity studies and susceptibility to chemical modification.
Meiergerd SM; Schenk JO
J Neurochem; 1994 Mar; 62(3):998-1008. PubMed ID: 8113819
[TBL] [Abstract][Full Text] [Related]
25. A dopaminergic neurotoxin, 1(R), 2(N)-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, N-methyl(R)salsolinol, and its oxidation product, 1,2(N)-dimethyl-6,7-dihydroxyisoquinolinium ion, accumulate in the nigro-striatal system of the human brain.
Maruyama W; Sobue G; Matsubara K; Hashizume Y; Dostert P; Naoi M
Neurosci Lett; 1997 Feb; 223(1):61-4. PubMed ID: 9058423
[TBL] [Abstract][Full Text] [Related]
26. Antiproliferative action of dopamine and norepinephrine in neuroblastoma cells expressing the human dopamine transporter.
Pifl C; Zezula J; Spittler A; Kattinger A; Reither H; Caron MG; Hornykiewicz O
FASEB J; 2001 Jul; 15(9):1607-9. PubMed ID: 11427501
[No Abstract] [Full Text] [Related]
27. Effect of temperature on dopamine transporter function and intracellular accumulation of methamphetamine: implications for methamphetamine-induced dopaminergic neurotoxicity.
Xie T; McCann UD; Kim S; Yuan J; Ricaurte GA
J Neurosci; 2000 Oct; 20(20):7838-45. PubMed ID: 11027249
[TBL] [Abstract][Full Text] [Related]
28. Pharmacological heterogeneity of the cloned and native human dopamine transporter: disassociation of [3H]WIN 35,428 and [3H]GBR 12,935 binding.
Pristupa ZB; Wilson JM; Hoffman BJ; Kish SJ; Niznik HB
Mol Pharmacol; 1994 Jan; 45(1):125-35. PubMed ID: 8302271
[TBL] [Abstract][Full Text] [Related]
29. Individual and combined effects of ethanol and cocaine on the human dopamine transporter in neuronal cell lines.
Ho M; Segre M
Neurosci Lett; 2001 Feb; 299(3):229-33. PubMed ID: 11165777
[TBL] [Abstract][Full Text] [Related]
30. Dopamine transporter mutants selectively enhance MPP+ transport.
Kitayama S; Wang JB; Uhl GR
Synapse; 1993 Sep; 15(1):58-62. PubMed ID: 8310426
[TBL] [Abstract][Full Text] [Related]
31. The bipyridyl herbicide paraquat produces oxidative stress-mediated toxicity in human neuroblastoma SH-SY5Y cells: relevance to the dopaminergic pathogenesis.
Yang W; Tiffany-Castiglioni E
J Toxicol Environ Health A; 2005 Nov; 68(22):1939-61. PubMed ID: 16263688
[TBL] [Abstract][Full Text] [Related]
32. The roles of dopamine transporter and Bcl-2 protein in the protection of CV1-P cells from 6-OHDA-induced toxicity.
Manáková S; Puttonen KA; Raasmaja A; Männistö PT
Toxicol Lett; 2004 Dec; 154(1-2):117-23. PubMed ID: 15475185
[TBL] [Abstract][Full Text] [Related]
33. A N-methyltransferase in human brain catalyses N-methylation of 1,2,3,4-tetrahydroisoquinoline into N-methyl-1,2,3,4-tetrahydroisoquinoline, a precursor of a dopaminergic neurotoxin, N-methylisoquinolinium ion.
Naoi M; Matsuura S; Takahashi T; Nagatsu T
Biochem Biophys Res Commun; 1989 Jun; 161(3):1213-9. PubMed ID: 2742585
[TBL] [Abstract][Full Text] [Related]
34. Catecholamine transporters and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity: studies comparing the cloned human noradrenaline and human dopamine transporter.
Pifl C; Hornykiewicz O; Giros B; Caron MG
J Pharmacol Exp Ther; 1996 Jun; 277(3):1437-43. PubMed ID: 8667208
[TBL] [Abstract][Full Text] [Related]
35. Cell death of dopamine neurons in aging and Parkinson's disease.
Naoi M; Maruyama W
Mech Ageing Dev; 1999 Nov; 111(2-3):175-88. PubMed ID: 10656535
[TBL] [Abstract][Full Text] [Related]
36. Expression and regulation of the human dopamine transporter in a neuronal cell line.
Zhang L; Elmer LW; Little KY
Brain Res Mol Brain Res; 1998 Aug; 59(1):66-73. PubMed ID: 9729282
[TBL] [Abstract][Full Text] [Related]
37. Salsolinol, a dopamine-derived tetrahydroisoquinoline, induces cell death by causing oxidative stress in dopaminergic SH-SY5Y cells, and the said effect is attenuated by metallothionein.
Wanpen S; Govitrapong P; Shavali S; Sangchot P; Ebadi M
Brain Res; 2004 Apr; 1005(1-2):67-76. PubMed ID: 15044066
[TBL] [Abstract][Full Text] [Related]
38. A dopamine transporter in human erythrocytes: modulation by insulin.
Azoui R; Cuche JL; Renaud JF; Safar M; Dagher G
Exp Physiol; 1996 May; 81(3):421-34. PubMed ID: 8737076
[TBL] [Abstract][Full Text] [Related]
39. Dopamine transporter-mediated cytotoxicity of beta-carbolinium derivatives related to Parkinson's disease: relationship to transporter-dependent uptake.
Storch A; Hwang YI; Gearhart DA; Beach JW; Neafsey EJ; Collins MA; Schwarz J
J Neurochem; 2004 May; 89(3):685-94. PubMed ID: 15086525
[TBL] [Abstract][Full Text] [Related]
40. Apoptosis induced by an endogenous neurotoxin, N-methyl(R)salsolinol, in dopamine neurons.
Naoi M; Maruyama W; Akao Y; Zhang J; Parvez H
Toxicology; 2000 Nov; 153(1-3):123-41. PubMed ID: 11090952
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
